PT - JOURNAL ARTICLE AU - Moorthy, Janani Dakshina AU - Ayyappan, Rajapriya AU - Usha, B TI - Phenotyping of Indian Polycystic Ovarian Syndrome on the basis of Biochemical Parameters: A retrospective analysis via Hierarchical Cluster Classification AID - 10.1101/2020.11.16.20232942 DP - 2020 Jan 01 TA - medRxiv PG - 2020.11.16.20232942 4099 - http://medrxiv.org/content/early/2020/11/18/2020.11.16.20232942.short 4100 - http://medrxiv.org/content/early/2020/11/18/2020.11.16.20232942.full AB - Objective We aimed to phenotype the Indian PCOS population based on their etiology for an effective treatment regimen.Design Retrospective analysis of biochemical data.Setting PCOS clinics in Tamil Nadu, IndiaPopulation or Sample Girls and women in age group 18 to 30 diagnosed as PCOS by RC.Method The statistical analysis was done using two-way cluster analysis function of SPSS v.22 to identify the phenotypes and the resolving biochemical parameter. Also, the population was segregated into three cohorts based on their age for further analysis.Main outcome measure Endocrine parameters like LH, FSH, estradiol, testosterone and thyroid profile. Biochemical parameters like complete lipid profile, blood glucose and insulin fasting. Body Mass Index (BMI).Results The statistical analysis reported two phenotypes among the Indian PCOS population, segregated based on their LH: FSH ratio. The phenotype with LH: FSH >2, had a hormonal imbalance and may have its etiology from Hypothalamus – Pituitary - Ovarian axis. The phenotype with LH: FSH < 2 had significant markers indicating the incidence of metabolic syndrome and may follow an insulin – dependent pathway for PCOS manifestation.Conclusion The PCOS population needs a comprehensive screening before deciding on a treatment regimen. All the PCOS patients need to be recommended to follow an active lifestyle since 80% of them are predisposed to a metabolic syndrome in their later ages.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAuthor Dakshina Moorthy Janani is supported by Women Scientist - A scheme, Department of Science and Technology, Govt. of India.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study involves data on human subjects. The Institutional review board of SRM Hospital, Medical college, and Research Institute has provided ethical clearance with reference no: 965/IEC/2016.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe complete data has been recoded in the format of a Microsoft Excel spreadsheet.